Plasma levels, biotransformation and excretion of oxatomide (R 35 443) in rats, dogs and man.
Plasma levels, biotransformation and excretion of oxatomide were studied after single oral doses of 14C-oxatomide in male rats, dogs and humans. Oxatomide was very well absorbed, and almost completely metabolized in the three species. Excretion of the metabolites was very rapid and complete within a few days; the 14C label was excreted more in the faeces (54-62%) than in the urine (27-40%). Major metabolic pathways of oxatomide were oxidative N-dealkylations at the piperazine nitrogens and at the benzimidazolone nitrogen in rats and man, and also aromatic hydroxylation at the benzimidazolone moiety in man. The main urinary metabolite in the three species was 2,3-dihydro-2-oxo-1H-benzimidazole-1-propanoic acid, resulting from the oxidative N-dealkylation at the 1-piperazine nitrogen.
D000328:Adult; D000818:Animals; D001562:Benzimidazoles / Q000097:blood / Q000378:metabolism / Q000652:urine; D001711:Biotransformation; D004285:Dogs; D005243:Feces / Q000737:chemistry; D006801:Humans; D008297:Male; D010879:Piperazines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D051381:Rats
D001562:Benzimidazoles; D010879:Piperazines; C015408:oxatomide